In addition, the treatment with clodronate, a non-aminobisphosphonate used to manage osteoarthritis, did not affect the modulation of miR-204-5p, but it was able to upregulate SOX9 expression and prevent miR-204-5p downregulation induced by Il beta 1 treatment. This evidence concerns the gene SOX9 and osteoarthritis.